| Product Code: ETC6738111 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Blockbuster Oncology Brands Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Blockbuster Oncology Brands Market Revenues & Volume, 2021 & 2031F |
3.3 China Blockbuster Oncology Brands Market - Industry Life Cycle |
3.4 China Blockbuster Oncology Brands Market - Porter's Five Forces |
3.5 China Blockbuster Oncology Brands Market Revenues & Volume Share, By Brands, 2021 & 2031F |
3.6 China Blockbuster Oncology Brands Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 China Blockbuster Oncology Brands Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in China |
4.2.2 Growing adoption of innovative oncology treatments |
4.2.3 Favorable government policies supporting oncology drug development |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval process for oncology drugs |
4.3.2 High cost associated with oncology treatments |
4.3.3 Competition from generic oncology drugs |
5 China Blockbuster Oncology Brands Market Trends |
6 China Blockbuster Oncology Brands Market, By Types |
6.1 China Blockbuster Oncology Brands Market, By Brands |
6.1.1 Overview and Analysis |
6.1.2 China Blockbuster Oncology Brands Market Revenues & Volume, By Brands, 2021- 2031F |
6.1.3 China Blockbuster Oncology Brands Market Revenues & Volume, By Opdivo, 2021- 2031F |
6.1.4 China Blockbuster Oncology Brands Market Revenues & Volume, By Keytruda, 2021- 2031F |
6.1.5 China Blockbuster Oncology Brands Market Revenues & Volume, By Perjeta, 2021- 2031F |
6.1.6 China Blockbuster Oncology Brands Market Revenues & Volume, By Ibrance, 2021- 2031F |
6.1.7 China Blockbuster Oncology Brands Market Revenues & Volume, By Tecentriq, 2021- 2031F |
6.1.8 China Blockbuster Oncology Brands Market Revenues & Volume, By Gazyva, 2021- 2031F |
6.1.9 China Blockbuster Oncology Brands Market Revenues & Volume, By Darzalex, 2021- 2031F |
6.1.10 China Blockbuster Oncology Brands Market Revenues & Volume, By Darzalex, 2021- 2031F |
6.2 China Blockbuster Oncology Brands Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 China Blockbuster Oncology Brands Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.2.3 China Blockbuster Oncology Brands Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.2.4 China Blockbuster Oncology Brands Market Revenues & Volume, By Multiple myeloma, 2021- 2031F |
6.2.5 China Blockbuster Oncology Brands Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.2.6 China Blockbuster Oncology Brands Market Revenues & Volume, By Others, 2021- 2031F |
7 China Blockbuster Oncology Brands Market Import-Export Trade Statistics |
7.1 China Blockbuster Oncology Brands Market Export to Major Countries |
7.2 China Blockbuster Oncology Brands Market Imports from Major Countries |
8 China Blockbuster Oncology Brands Market Key Performance Indicators |
8.1 Number of oncology clinical trials conducted in China |
8.2 Adoption rate of targeted oncology therapies in China |
8.3 Investment in oncology research and development in China |
9 China Blockbuster Oncology Brands Market - Opportunity Assessment |
9.1 China Blockbuster Oncology Brands Market Opportunity Assessment, By Brands, 2021 & 2031F |
9.2 China Blockbuster Oncology Brands Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 China Blockbuster Oncology Brands Market - Competitive Landscape |
10.1 China Blockbuster Oncology Brands Market Revenue Share, By Companies, 2024 |
10.2 China Blockbuster Oncology Brands Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here